Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial

Go back to Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
Bristol-Myers Squibb (NYSE: BMY) Delayed: 63.77 +0.16 (0.25%)
Previous Close $63.61    52 Week High $77.12 
Open $63.49    52 Week Low $49.03 
Day High $64.00    P/E 41.41 
Day Low $63.00    EPS $1.54 
Volume 5,377,075